1.

S3 File -

1.

Flow chart of patient inclusion.

1.

Patients working in a vital profession (A) and in the medical sector (B) in the SARS-Cov-2 positive-tested, negative-tested, and control groups.

1.

Diagram for the flow of participants for part 1 of the study (prospective cohort).

1.

Diagram for the flow of participants for part 2 of the study (qRT-PCR positive participants only).

1.

Percentage of patients with intermediate-thickness (1.2–3.5 mm) melanoma on trunk or limb in Southern Netherlands who underwent SLNB (Sentinel Lymph Node Biopsy).

2.

Percentage of patients with intermediate-thickness (1.2–3.5 mm) melanoma on trunk or limb in Southern Netherlands who underwent SLNB (Sentinel Lymph Node Biopsy).

3.

Percentage of patients with intermediate-thickness (1.2–3.5 mm) melanoma on trunk or limb in Southern Netherlands who underwent SLNB (Sentinel Lymph Node Biopsy).

1.

Survival of patients with intermediate-thickness (1.2–3.5 mm) melanoma on trunk or limb in Southern Netherlands diagnosed 2000–2016 followed up until Feb 2021 by SLNB (Sentinel Lym...

2.

Survival of patients with intermediate-thickness (1.2–3.5 mm) melanoma on trunk or limb in Southern Netherlands diagnosed 2000–2016 followed up until Feb 2021 by SLNB (Sentinel Lym...

3.

Survival of patients with intermediate-thickness (1.2–3.5 mm) melanoma on trunk or limb in Southern Netherlands diagnosed 2000–2016 followed up until Feb 2021 by SLNB (Sentinel Lym...

1.

The SARS-CoV-2 outbreak in the Netherlands.

1.

Stringency government response in The Netherlands and Belgium.

2.

Stringency government response in The Netherlands and Belgium.

3.

Stringency government response in The Netherlands and Belgium.

4.

Stringency government response in The Netherlands and Belgium.

5.

Stringency government response in The Netherlands and Belgium.

1.

Number of observations per capita per province in the Netherlands.